The Epidemiology, Management, and the Associated Burden of Mental Health, Atopic and Autoimmune Conditions, and Common Infections in Alopecia Areata

Status: Active, not recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational

This study series consists of four related studies and aims to explore and describe many important elements of alopecia areata over three key areas: (1) the current epidemiology of alopecia areata, (2) the prevalence and incidence of psychiatric co-morbidities in people with alopecia areata, (3) the prevalence and incidence of autoimmune and atopic conditions in people with alopecia areata, and (4) the incidence of common infections in people with alopecia areata.

Participation Requirements
Sex: All

• Patients contributing to Royal College of General Practitioners Research and Surveillance Centre(RCGP RCS) primary care database between January 1, 2009 and December 31, 2018, will be eligible for inclusion.

• Only patients aged ≥18 will be eligible for studies 2 and 3.

• Only patients aged ≥ 18 and ≤ 65 will be included in the unemployment and sick day analysis (study 2)

Other Locations
United Kingdom
Momentum Data Ltd
Time Frame
Start Date: October 1, 2020
Estimated Completion Date: December 31, 2021
Target number of participants: 51955
Patients with a confirmed diagnosis of Alopecia areata within the study period will be included as cases for analysis.
The control cohorts will be defined by matching cases with patients who have never been diagnosed with Alopecia areata either prior to or during the study period, by age and sex, at General Practice practice level.
Collaborators: Pfizer, University of Surrey, University of Oxford
Leads: Momentum Data

This content was sourced from

Similar Clinical Trials